Development of a CCR2 targeted 18F-labeled radiotracer for atherosclerosis imaging with PET.
Ontology highlight
ABSTRACT: Atherosclerosis is a chronic inflammatory disease and the leading cause of morbidity and mortality worldwide. CC motif chemokine ligand 2 and its corresponding cognate receptor 2 (CCL2/CCR2) signaling has been implicated in regulating monocyte recruitment and macrophage polarization during inflammatory responses that plays a pivotal role in atherosclerosis initiation and progression. In this study, we report the design and synthesis of a novel 18F radiolabeled small molecule radiotracer for CCR2-targeted positron emission tomography (PET) imaging in atherosclerosis. The binding affinity of this radiotracer to CCR2 was evaluated via in vitro binding assay using CCR2+ membrane and cells. Ex vivo biodistribution was carried out in wild type mice to assess radiotracer pharmacokineti
SUBMITTER: Zhang X
PROVIDER: S-EPMC10964492 | biostudies-literature | 2024 Mar-Apr
REPOSITORIES: biostudies-literature
ACCESS DATA